Cinnopar
Cinnopar contains Teriparatide, a recombinant human parathyroid hormone analog used to treat osteoporosis and rebuild bone density in individuals at high risk of fractures.
Overview
Cinnopar Injection is a prescription medication containing Teriparatide, an active recombinant human parathyroid hormone fragment. It is prescribed for the management of severe osteoporosis in postmenopausal women and men who are at high risk of bone fractures. Cinnopar is available for reliable home delivery across Pakistan through PakMeds.
Important Information
Prescription medicine: Cinnopar is supplied only against a valid prescription from a registered doctor. Use it only as directed by your doctor.
Cold-chain product: Cinnopar must be kept refrigerated between 2°C and 8°C. PakMeds delivers it in temperature-controlled packaging. Refrigerate it as soon as it arrives and do not freeze it.
Key Benefits of Cinnopar
Helps stimulate new bone formation to increase bone mineral density.
Reduces the risk of vertebral and non-vertebral fractures in osteoporosis patients.
Treats bone loss associated with sustained systemic glucocorticoid therapy.
Provides targeted bone-building action compared to traditional anti-resorptive treatments.
Cinnopar Ingredients and Usage
Cinnopar contains Teriparatide, which belongs to the class of agents known as parathyroid hormone analogs. Unlike traditional osteoporosis medications that slow down bone breakdown, Teriparatide acts as an anabolic agent that actively stimulates new bone formation.
This medication is indicated for the treatment of postmenopausal osteoporosis in women at high risk for fracture. It is also prescribed to increase bone mass in men with primary or hypogonadal osteoporosis, and for the treatment of glucocorticoid-induced osteoporosis in adults.
How Does Cinnopar Work?
Teriparatide is identical to the biologically active sequence of endogenous human parathyroid hormone. Intermittent exposure to Teriparatide stimulates osteoblast activity, which are the cells responsible for forming new bone tissue.
By promoting osteoblastic bone formation, Cinnopar enhances bone microarchitecture, increases bone mineral density, and strengthens structural integrity to lower the likelihood of bone fractures.
How to Use Cinnopar
Cinnopar is supplied as a solution for subcutaneous injection. It is administered under the skin into the thigh or abdominal wall.
A healthcare provider will instruct you on the proper technique for self-injection using the device. Always strictly follow the specific administration guidance provided by your prescribing doctor.
Do not alter your schedule or attempt to stop treatment without consulting your physician. If you experience dizziness or a fast heartbeat after injection, sit or lie down until symptoms pass.
Cinnopar Side Effects
Like all medicines, Cinnopar can cause side effects, although not everyone experiences them. Inform your healthcare provider if any symptom persists or causes discomfort.
Dizziness or lightheadedness
Nausea
Pain in the extremities
Headache
Transient high blood calcium levels
Injection site reactions such as redness or swelling
Muscle cramps
Palpitations or rapid heart rate
Warnings
Teriparatide has been associated with an increased risk of osteosarcoma in animal studies, so duration of use is strictly limited by your doctor.
This medication should not be used in patients with Paget's disease of bone or unexplained elevations of alkaline phosphatase.
Cinnopar is contraindicated in patients with prior radiation therapy involving the skeleton.
Patients with pre-existing hypercalcemia or bone metastases should not take this medication.
Precautions and Who Should Avoid It
Tell your doctor if you have a history of kidney stones or severe renal impairment.
Cinnopar is not recommended for use during pregnancy or while breastfeeding.
Inform your physician if you experience persistent nausea, vomiting, constipation, or muscle weakness, as these may be signs of elevated blood calcium.
Disclose all known drug allergies and medical conditions to your doctor before beginning therapy.
Drug and Food Interactions
Care should be taken when used concurrently with digitalis or digoxin, as transient hypercalcemia may predispose patients to digitalis toxicity.
Inform your doctor about any over-the-counter calcium or vitamin D supplements you are taking.
Disclose all prescription and non-prescription medications to your pharmacist or doctor before starting Cinnopar.
Cinnopar Storage Conditions
Cinnopar is a temperature-sensitive cold chain item. It must be kept refrigerated between 2°C and 8°C in its original pack and must not be frozen. Keep the cap on the pen to protect it from light and keep out of the reach of children. The pen must be discarded 28 days after first use, even if there is medicine remaining
Frequently Asked Questions
What is Cinnopar used for?
Cinnopar is used to treat severe osteoporosis in postmenopausal women and men who are at a high risk of bone fractures.
How is Cinnopar administered?
Cinnopar is given as a subcutaneous injection into the thigh or abdomen as directed by your healthcare specialist.
Does Cinnopar require cold storage?
Yes, Cinnopar requires cold chain storage and must be refrigerated between 2°C and 8°C at all times. Do not freeze it.
Can I buy Cinnopar online in Pakistan?
Yes, you can order Cinnopar online from PakMeds with proper temperature-controlled delivery across Pakistan, provided you have a valid prescription.
Customer Reviews
No reviews yet. Be the first to review this product!
Login to write a review